Analog Devices Inc. completed the acquisition of Maxim Integrated Products in August increasing its head count to 10,000 engineers. The deal was originally valued at nearly $21 billion in stock when announced in 2020.
RELATED: Analog chips are "red hot" as Analog buys Maxim for $21B
This week, Analog announced two new devices offering examples of the kind of work to come from the combined entity.
A new integrated circuit, the MAX77659, is a single inductor multiple output (SIMO) power management chip for use in wearables, hearables and IoT devices. The company said it will charge devices faster while using less space than any comparable device today.
It is rated to deliver more than four hours of play time after a 10-minute charge. It uses a single inductor to power multiple rails, which can reduce the BOM by 60% and reduce device size by half.
The MAX77659 is available now for $2.65 in lots of 1,000 units.
Analog Devices also announced a single-chip Analog Front End (AFE) to measure four vital signs: electrocardiogram, heart rate, blood oxygen saturation and respiration. The MAX86178 offers synchronized optical PPG and ECG timing.
With three healthcare subsystems on a single chip, Analog said it can offer new approaches for chronic disease management and contagious disease diagnosis, even COVID-19. It will be used in small body-worn devices such as a monitor worn on the chest.
The MAX86178 is available now.
The new AFE chip “gives the opportunity for earlier [disease] detection and with the advent of AI and analytics, more data driven decisions can be made,” said Andrew Baker, managing director of the industry and healthcare business unit for Analog Devices, in an interview.
Analog said earlier that it expects the acquisition will allow it to serve 125,000 customers with 50,000 products. The acquisition combined the second and third largest linear analog chip makers, putting Analog in competition with Texas instruments.
Editor’s Note: Analog Devices has a booth at Sensors Converge in San Jose Sept. 22-23.